C909-0147 Screening compound: ethyl 4-[({12-oxo-6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazolin-2-yl}carbamoyl)formamido]piperidine-1-carboxylate

C909-0147 Screening compound: ethyl 4-[({12-oxo-6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazolin-2-yl}carbamoyl)formamido]piperidine-1-carboxylate
C909-0147 Screening compound: ethyl 4-[({12-oxo-6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazolin-2-yl}carbamoyl)formamido]piperidine-1-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound C909-0147
ethyl 4-[({12-oxo-6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazolin-2-yl}carbamoyl)formamido]piperidine-1-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C909-0147

Molecular Formula

C23H29N5O5 (C23 H29 N5 O5)

Compound Name

ethyl 4-[({12-oxo-6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazolin-2-yl}carbamoyl)formamido]piperidine-1-carboxylate

IUPAC name

ethyl 4-[({12-oxo-6H7H8H9H10H12H-azepino[21-b]quinazolin-2-yl}carbamoyl)formamido]piperidine-1-carboxylate

SMILES

CCOC(N(CC1)CCC1NC(C(Nc(cc1)cc2c1N=C(CCCCC1)N1C2=O)=O)=O)=O

InChI

InChI=1S/C23H29N5O5/c1-2-33-23(32)27-12-9-15(10-13-27)24-20(29)21(30)25-16-7-8-18-17(14-16)22(31)28-11-5-3-4-6-19(28)26-18/h7-8,14-15H,2-6,9-13H2,1H3,(H,24,29)(H,25,30)

InChI Key

UZPLBVIBWFNPMH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14807987

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

455.51

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.518

Distribution Coefficient, logD

1.277

Water Solubility, LogSw

-2.51

Polar Surface Area

97.001

Acid Dissociation Constant (pKa)

7.53

Base Dissociation Constant (pKb)

3.91

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.20

C909-0147 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C909-0147 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C909-0147?
Check Price and Availability of C909-0147, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C909-0147 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C909-0147
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C909-0147
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C909-0147 available by request